Objectives: To describe endometrial morphology using the IETA terminology in women with abnormal uterine bleeding undergoing unenhanced ultrasonography (UUS) with colour Doppler imaging (CD) and fluid instillation sonography (FIS) and compare it with histology. Methods: Prospective observational multicenter study of 2856 women presenting with abnormal uterine bleeding. UUS with CD was performed in all cases and FIS in 1508. In 2116, endometrial histology was available (study population). The histological endpoints were endometrial atrophy, proliferative and secretory endometrium, hyperplasia without atypia, polyp, intracavitary fibroid, atypical hyperplasia, and cancer. For fluid instillation sonography the main histological endpoints were polyps, intracavitary fibroids and cancer. Results: Median (range) age was 49 years (19-92) with a median BMI of 24.9 (16.0-72.1). Of all women 38% were postmenopausal. Endometrial polyps were histologically confirmed in 751 cases, intracavitary fibroids in 223 and endometrial cancer in 137. For each histological endpoint typical morphological features (range of sensitivities for the different endpoints) according the IETA terminology could be found at UUS including endometrial thickness (27-59%), echogenicity (45-80%), midline (23-90%), junctional zone (53-77%), colour score (45-83%) and vascular pattern (52-78%). For FIS typical features (sensitivities) included a localised lesion (50-100%), lesion echogenicity (61-83), outline (60-95%) and colour score (44-69%). None of the women with a thin endometrium < 3mm and only one with a three-layer pattern (1/273), a visible endometrial midline (1/440) or the presence of a single vessel without branching (1/54) had cancer: NPV of 100%, 99%, 99% and 99% respectively. The presence at FIS of a single vessel without branching within an endometrial lesion makes cancer most unlikely (n = 1; NPV of 99.5%).
Objectives: To describe non-sonographic characteristics (clinical history, lifestyle and constitution) of women with abnormal uterine bleeding recruited in the IETA-1 multicentre prospective study and compare them between women with benign and malignant endometrium. Methods: Prospective observational multicentre study of 2856 consecutive women presenting with abnormal uterine bleeding, of which 2116 had endometrial histology available. The histological endpoints were endometrial atrophy, proliferative/secretory endometrium, endometrial hyperplasia without atypia, endometrial polyp, intracavitary fibroid, atypical endometrial hyperplasia, and endometrial malignancy. Non-sonographic characteristics included age, parity, BMI, bra cup size, personal history of cancer, use of hormonal therapy, anticoagulant therapy, level of physical exercise, alcohol consumption and smoking habits. Results: Of all 2116 included women, 38% were postmenopausal, 26% were on hormonal therapy. The median (interquartile range) age of women with endometrial cancer was 69 years (59-75), versus 49 (42-55) for those with benign outcomes. Patients with atypical hyperplasia or cancer had a median BMI of 28 (range 25-32). In case of a personal history of breast cancer (n = 112), 21% had endometrial atrophy and 37% endometrial polyp. Age at menopause (50 years), bra cup size (B) and parity (2) did not differ among outcome groups. Most women with endometrial cancer were postmenopausal (88%), did not take hormonal therapy (90%), had never smoked (61%), reported a moderate alcohol consumption <7 units per week (57%), no or limited physical exercise (44% and 18% respectively) and did not take anticoagulant therapy (82%). Conclusions: Only the traditional risk factors of age and BMI appeared to be more common in patients with endometrial cancer or atypical hyperplasia. Further risk stratification is needed to assess women presenting with abnormal uterine bleeding and predict which patients are more likely to develop endometrial malignancy.
